Personalised medicine

Show results for

Unknown (2100)
Genomics (70)
Proteomics (18)
Transcriptomics (11)
Models (8)
Multiomics (6)
Genomic (4)
Metabolomics (1)

Organisms

Homo sapiens (36)
Andropogon gerardi (17)
Bacteria (17)
Botrytis cinerea (17)
Canis lupus familiaris (17)
Clostridium perfringens (17)
Cnidaria (17)
Cricetulus griseus (17)
Eukaryota (17)
Fasciola (17)
Hepatitis B virus (17)
Human betaherpesvirus 5 (17)
Japanese encephalitis virus group (17)
Mesocricetus auratus (17)
Miscanthus x giganteus (17)
Mycobacterium tuberculosis (17)
Orthoflavivirus (17)
Panicum virgatum (17)
Platyhelminthes (17)
Pseudomonas aeruginosa AES-1R (17)
Rickettsia (17)
Saccharomyces cerevisiae (17)
Schizosaccharomyces pombe (17)
Severe acute respiratory syndrome coronavirus 2 (17)
Shigella (17)
Sorghastrum nutans (17)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (17)
Streptococcus pneumoniae (17)
Streptomyces coelicolor A3(2) (17)
Mus musculus (3)

Organisms

Homo sapiens (30)
Rattus norvegicus (2)
Mus musculus (2)

Repository

ENA (43)
EGA (26)
pride (17)
geo (8)
Cell Collective (6)
biostudies-arrayexpress (4)
dbGaP (4)
BioModels (2)
MetaboLights (1)
PanoramaPublic (1)

Tissue

Cell culture (7)
Colon (3)
Epithelial cell (3)
Rectum (3)
Brain (2)
Colonic cancer cell line (2)
Rectal cancer cell line (2)
Blood plasma (1)
Colonic cancer cell (1)
Endothelial cell of umbilical vein (1)
HeLa cell (1)
Heart (1)
Kidney (1)
Layer of synovial tissue (1)
Liver (1)
Permanent cell line cell (1)
Rectal cancer cell (1)
Synovial tissue (1)
Testis (1)
Urine (1)

Disease

Colon cancer (3)
Rectum cancer (3)
Cervix carcinoma (2)
Breast cancer (1)
Cardiovascular system disease (1)
Malignant neoplasm of ovary (1)
Rheumatoid arthritis (1)

Technology Type

Mass Spectrometry (17)
Shotgun proteomics (16)
Illumina HiSeq 2000, ILLUMINA (2)
Illumina HiSeq 2000 (1)
Illumina MiSeq (1)
Mass spectrometry (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
SRM/MRM (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Illumina HiSeq 2500 (1)
Direct infusion MS - negative (1)
Direct infusion MS - positive (1)

Publication Date

2025 (6)
2023 (4)
2021 (3)
2017 (3)
2026 (2)
2022 (2)
2018 (2)
2013 (2)
2010 (2)
2020 (2)
2019 (2)
2014 (1)
2024 (1)

Metabolite Name

N-Desmethyldoxepin (1)
6,7-Dihydro-2,3-dimethyl-5H-cyclopentapyrazine (1)
6,7-Dihydro-2,6-dimethyl-5H-cyclopentapyrazine (1)
1,4-Bis-(1,1-dimethylethyl)-benzene (1)
Prudomestin (1)
9-Azabicyclo[3.3.1]nonan-3-one (1)
3,4',5,7-Tetrahydroxy-6-methoxyflavone (1)
1-Isothiocyanato-2-(methylthio)ethane (1)
LysoPC(20:4/0:0) (1)
Deoxyfructosazine (1)
2,3,6,7-Tetrahydrocyclopent[b]azepin-8(1H)-one (1)
Pyrrolidino-[1,2E]-4H-2,4-dimethyl-1,3,5-dithiazine (1)
Diethylenetriamine (1)
6,7-Dihydro-2,5-dimethyl-5H-cyclopentapyrazine (1)
1-(Methylthio)-propane (1)
Diethyl sulfide (1)
Monomethyl phenylphosphonate (1)
3,4',5-Biphenyltriol (1)
2-(Methylthio)propane (1)
8-hydroxymirtazapine (1)
Demethylbatatasin IV (1)
2',8-Dihydroxy-3',4',5',7-tetramethoxyflavan (1)
1-Methoxyspirobrassinin (1)
Valylmethionine (1)
3-Hydroxy-9Z-octadecenoylcarnitine (1)
Stearidonyl carnitine (1)
9'-desmethylgranisetron (1)
Alpha-Cotonefuran (1)
N-Methylnicotinium (1)
Nicotine imine (1)

IsPrivate

False (2)

Submitter Keywords

Manuscript Accepted (1)

First Public Date

2017 (18)
2018 (5)
2026 (3)
2025 (3)
2024 (3)
2020 (3)
2015 (3)
2023 (2)
2014 (2)
2021 (1)

Modelling Approach

Boolean model (1)
Constraint-based model (1)

Study type

Transcription profiling by array (2)
Genotyping by array (1)
RNA-seq of coding RNA (1)

Release Date

2025 (394)
2022 (290)
2024 (259)
2023 (247)
2021 (242)
2020 (152)
2019 (110)
2018 (88)
2017 (79)
2026 (64)
2016 (56)
2015 (39)
2014 (33)
2013 (19)
2012 (11)
2011 (11)
2010 (5)
2006 (2)
2009 (1)
2007 (1)
2004 (1)

Lab affiliation

Chair of Proteomics and Bioanalytics, Technische Universität München, Germany (3)
School of Biomedical Sciences, Faculty of Medicine and Health, UNSW Sydney (2)
1. Monash Proteomics and Metabolomics Facility, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia 2. School of Clinical Sciences, Department of Medicine, Monash University, Clayton, Victoria, Australia (1)
Chair, Quantitative Proteomics Director, Proteome Center Tuebingen Interfaculty Institute for Cell Biology University of Tuebingen Auf der Morgenstelle 15 72076 Tuebingen Germany (1)
Faculty of Medicine of the University of Porto Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal (1)
Mass Spectrometry Facility Barts Cancer Institute Queen Mary, University of London John Vane Science Centre, Charterhouse Square, London EC1M 6BQ (1)
ProCan®, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia. (1)
Proteomics Laboratory Head and Acting Co-Division Head. Systems Biology and Personalised Medicine Division WEHI, Australia (1)
Proteomics and Metabonomics Laboratory IRCCS-Fondazione Santa Lucia Via del Fosso di Fiorano 64/65, 00145, Rome Italy (1)
Proteomics and Metabonomics Unit Fondazione Santa Lucia-IRCCS Via del Fosso di Fiorano 64, 00145 Rome, Italy (1)
Systems Biology Ireland, School of Medicine, University College Dublin, Ireland (1)
Systems Biology and Personalised Medicine, Walter & Eliza Hall Institute (1)
The Nancy and Stephen Grand Israel National Center for Personalised Medicine Weizmann Institute of Science (1)
The Nancy and Stephen Grand Israel National Center for Personalised Medicine Weizmann Institute of Science, Rehovot 76100, Israel Tel. 972-8-9344902 (1)

Previous page
1 / 222
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 222
Next page

Sort by:

Relevance

Page size

Personalised therapeutic management of epileptic patients guided by pathway-driven breath metabolomics

BACKGROUND: Therapeutic management of epilepsy remains a challenge, since optimal systemic antiseizure medication (ASM) concentrations do not always correlate with improved clinical outcome and minimal side effects. We tested the feasibility of non-invasive real-time breath metab...

2021-06-21 | MTBLS2400 | MetaboLights

Personalised medicine in asthma: from curative to preventive medicine.

Not available

S-EPMC9489193 | biostudies-literature

10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020.

Not available

S-EPMC7435254 | biostudies-literature

Asthma genetics and personalised medicine.

Not available

S-EPMC4768462 | biostudies-literature

Personalised medicine for nonsmall cell lung cancer.

Not available